Add Formweb to your mobile device
Following is a P and T Committee update (from the May 22nd meeting). Starting date for specific programs is 1 June 2018, unless otherwise noted. Please let me know if you have any questions or comments. Don’t forget to check the “New Drug Monitoring Spotlight” section of the website, which provides important monitoring information about newly approved drugs. Also, attached is the updated version of the “Not Stocked, Not Ordered” drug list with the new additions highlighted in red.
Below is the memo with links to the drug monographs, protocols, and formulary documents. Click to access the full P&T packet for this month, or here to access the P&T packet archive.
|
Drug or Drug Class |
Formulary Decision |
Comments |
| benralizumab (Fasenra) | Formulary, Restricted | Restricted to use in the outpatient setting. Defer initiation until after discharge. Inpatients may use own supply – must be administered by healthcare provider. |
| amantadine Extended – Release (Gocovri) |
Non-formulary Automatic Interchange Approved |
Automatic interchange to immediate release amantadine. |
| pregabalin Extended – Release (Lyrica CR) |
Non-formulary Automatic Interchange Approved |
Automatic interchange to immediate release pregabalin (Lyrica to go generic in 2018) |
| buprenorphine Extended-Release (Sublocade) | Non-Formulary | Defer therapy to non-Huntsville Hospital outpatient settings. |
| minocycline (Ximino) |
Non-formulary Automatic Interchange Approved |
This is a tetracycline related acne product and is interchanged to regular minocycline generic in similar total daily dosages. |
| Maggot larval therapy (BioBag by BioMonde) | Formulary | Because of several advantages, the BioMonde maggot product was approved to take the place of the Monarch product on the formulary. |
| Conivaptan (Vaprisol) | Changed from Formulary, Restricted to Non-Formulary. | Reclassified as non-formulary due to no utilization resulting in wasted stock. Alternative therapies include tolvaptan and 3% sodium chloride. |
| edrophonium (Enlon) | Reclassified as Non-Formulary | Enlon is no longer available on market. Similar drugs are neostigmine and pyridostigmine. |
| Prenatal Vitamin Formulary Update | Workhorse Formulation Change | The stocked prenatal vitamin serving as the formulary workhorse will be changed to a chewable tablet formulation. |
| 2017 Antibiogram Update | Reviewed & Approved | 2017 Antibiogram will be available on the Huntsville Hospital intranet. |